Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 30-04 (MA.27) 

A randomized phase III trial of exemestane vs. anastrozole in postmenopausal women with receptor positive primary breast cancer

DESIGN

Please click on the picture to see a larger version

Results & Publications


Presentations


Publications

Study Chairs
IBCSG: Dr. Manuela Rabaglio - Bern, Switzerland
NCIC CTG: Dr. Paul Goss - Boston, USA

Trial Coordinators
Holly Shaw

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg30_MA27@fstrf.org


Date of Activation
April 12, 2005

Date of Closure
December 15, 2006

Targeted Accrual
6840 patients

Final Accrual
7576 patients


Results Publications Results & Publications
Other Pathology


News

13.04.2016:
PINK GOLF TOUR 2016 Golf  Kyburg 25.5.2016 / Golf Gams 30.5.2016 / Golf Winterberg 7.7.2016 

14.03.2016:
New publications are available 

14.03.2016:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 18 and 19, 2017 .

All News

 
  Print